Buxton Helmsley is an investment management firm that seeks to provide alternative investment opportunities enabling investors to efficiently achieve strategic diversification, risk reduction, and asset profile strengthening, among global asset markets.
Press Release - NOV 5, 2021

Buxton Helmsley Publicly Responds to Resignation of Mallinckrodt Plc. SVP, Finance, Days After Open Letter to U.S. SEC Detailing Accounting Fraud

NEW YORK--(BUSINESS WIRE)--The Buxton Helmsley Group, Inc. (together with certain of its affiliates and clients, "BHG" or "we"), the New York City-based investment advisor to clients with significant holdings of Mallinckrodt Plc. ("Mallinckrodt" or the "Company") (OTC: MNKKQ) common stock, and with the backing of other various shareholders, today issued an open letter responding to the resignation of the Company's Senior Vice President of Finance, Ms. Kathy Schaefer, occurring just days after BHG filed an open letter to the U.S. Securities and Exchange Commission outlining/detailing numerous instances of fraud, including accounting fraud, bankruptcy fraud, electoral fraud, proxy fraud, and insider trading on undisclosed information by the Company's board of directors and management.

The full open letter to the Company's board of directors, in response to Ms. Schaefer's departure, may be found at (along with all previous letters): http://www.revivemallinckrodt.com/

Members of the Mallinckrodt Plc. Board of Directors: Mark C. Trudeau, Angus Russell, Anne C. Whitaker, Joann A. Reed, Carlos V. Paya (M.D., Ph.D.), J. Martin Carroll, Paul R. Carter, David Norton, Kneeland Youngblood, and David Carlucci.

About Buxton Helmsley: The Buxton Helmsley Group, Inc. ("BHG") is a premier financial service, asset management and securities research firm, providing an array of services to a diversified group of individuals, corporations, trusts and other entities. The firm is headquartered in New York City.

Media Contact:
Public Relations and Corp. Comm.
Tel: +1 (212) 561 - 5540, Option 4

Global Media Inquiries
+1 (212) 561-5540, Option 4
Non-Media Inquiries
+1 (212) 561-5540